APPLICATION
BLA761388
TYPE
BLA
ORIGINAL APPROVAL
2024-06-20
LATEST ACTION
2025-05-14
ROUTE
SUBCUTANEOUS, INTRAVENOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
PIASKYPrescription
CROVALIMAB-AKKZ 340MG/2ML(170MG/ML) · INJECTABLE · INTRAVENOUS
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.